The Serum Institute Of India
-
{
- All
- News
- Videos
-
Oxford Scientists Are Developing First-Ever Vaccine For Rare Bundibugyo Ebola Strain
Researchers at Oxford University are developing the novel jab targeting the rare strain. The World Health Organization says
-
Oxford, Serum Institute Of India Join Forces For Next-Generation Malaria Vaccine
Oxford and Serum Institute of India have partnered to develop the R78C malaria vaccine. Experts say this next-generation shot could improve protection by targeting multiple stages of the parasite lifecycle.
-
India Gets New Vaccine Tools To Fight Tuberculosis In Adolescents: Not 'A Magic Bullet' But A Good Breakthrough
While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, with a large, independent Phase III clinical trial led, funded and sponsored by the Indian Council of Medical Research (ICMR).
-
Serum Institute's Cyrus Poonawalla Buys Raja Ravi Varma Painting For Record Rs 167 Crore
Managing director of the Serum Institute of India, Dr Cyrus S Poonawalla, acquired Raja Ravi Varma's iconic painting Yashoda and Krishna
-
Virat Kohli May Play For New Owners As RCB Heads For Big Change
Earlier this year, RCB lifted its maiden title by trouncing Punjab Kings in the final of the 18th edition of the cash-rich league.
-
"Not Humanly Possible To...": Adar Poonawalla On Work Hours vs Productivity
Amid the nationwide debate on work-life balance after problematic remarks by some industry leaders, Adar Poonawalla, CEO of vaccine manufacturer Serum Institute, has said it is not humanly possible to be productive beyond a certain number of hours
-
"Really Hate Mosquitoes": At Davos, Adar Poonawalla Explains Vaccine Plans To NDTV
Serum Institute of India CEO Adar Poonawalla spoke to NDTV on a range of issues, key among them the vaccine for malaria and other mosquito-borne diseases, on the sidelines of the World Economic Forum (WEF) meeting in Davos.
-
"My Wife Loves Staring At Me": Adar Poonawalla Mocks L&T Chief's Remark
Serum Institute of India CEO Adar Poonawalla has weighed in on the ongoing debate about work-life balance, advocating for the importance of quality over the quantity of work hours.
-
Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa
A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.
-
Serum Institute Begins Shipments Of Malaria Vaccine 'R21/Matrix-M' To Africa
Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Couple Allege Daughter Died After Taking Covishield, To Sue AstraZeneca
The parents of a young woman who died allegedly after being given Covishield are planning to sue the world's largest vaccine maker and the British pharma giant that had developed the vaccine during the Covid pandemic.
-
Serum Institute Boosts Supply Of Cervical Cancer Shots Ahead Of Mass Drive
Serum Institute of India aims to significantly boost supply of its human papillomavirus (HPV) vaccine as it gears up to provide its shots to the government at cheaper rates for an immunisation campaign this year against the cancer-causing virus.
-
Sharad Pawar Demands Bharat Ratna For Serum Institute Founder Cyrus Poonawalla
Praising the work done by the founder of the Serum Institute of India (SII), in the field of vaccine production, founder of Nationalist Congress Party (NCP) Sharad Pawar demanded that Cyrus Poonawalla be honoured with the Bharat Ratna award.
-
Vaccine Maker Adar Poonawalla To Buy Mansion In London's Mayfair. It Costs...
Billionaire CEO of Serum Institute of India, Adar Poonawalla, has sealed a deal to buy a multi-million-pound mansion in London's Mayfair, the Financial Times reported.
-
Oxford Scientists Are Developing First-Ever Vaccine For Rare Bundibugyo Ebola Strain
Researchers at Oxford University are developing the novel jab targeting the rare strain. The World Health Organization says
-
Oxford, Serum Institute Of India Join Forces For Next-Generation Malaria Vaccine
Oxford and Serum Institute of India have partnered to develop the R78C malaria vaccine. Experts say this next-generation shot could improve protection by targeting multiple stages of the parasite lifecycle.
-
India Gets New Vaccine Tools To Fight Tuberculosis In Adolescents: Not 'A Magic Bullet' But A Good Breakthrough
While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, with a large, independent Phase III clinical trial led, funded and sponsored by the Indian Council of Medical Research (ICMR).
-
Serum Institute's Cyrus Poonawalla Buys Raja Ravi Varma Painting For Record Rs 167 Crore
Managing director of the Serum Institute of India, Dr Cyrus S Poonawalla, acquired Raja Ravi Varma's iconic painting Yashoda and Krishna
-
Virat Kohli May Play For New Owners As RCB Heads For Big Change
Earlier this year, RCB lifted its maiden title by trouncing Punjab Kings in the final of the 18th edition of the cash-rich league.
-
"Not Humanly Possible To...": Adar Poonawalla On Work Hours vs Productivity
Amid the nationwide debate on work-life balance after problematic remarks by some industry leaders, Adar Poonawalla, CEO of vaccine manufacturer Serum Institute, has said it is not humanly possible to be productive beyond a certain number of hours
-
"Really Hate Mosquitoes": At Davos, Adar Poonawalla Explains Vaccine Plans To NDTV
Serum Institute of India CEO Adar Poonawalla spoke to NDTV on a range of issues, key among them the vaccine for malaria and other mosquito-borne diseases, on the sidelines of the World Economic Forum (WEF) meeting in Davos.
-
"My Wife Loves Staring At Me": Adar Poonawalla Mocks L&T Chief's Remark
Serum Institute of India CEO Adar Poonawalla has weighed in on the ongoing debate about work-life balance, advocating for the importance of quality over the quantity of work hours.
-
Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa
A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.
-
Serum Institute Begins Shipments Of Malaria Vaccine 'R21/Matrix-M' To Africa
Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Couple Allege Daughter Died After Taking Covishield, To Sue AstraZeneca
The parents of a young woman who died allegedly after being given Covishield are planning to sue the world's largest vaccine maker and the British pharma giant that had developed the vaccine during the Covid pandemic.
-
Serum Institute Boosts Supply Of Cervical Cancer Shots Ahead Of Mass Drive
Serum Institute of India aims to significantly boost supply of its human papillomavirus (HPV) vaccine as it gears up to provide its shots to the government at cheaper rates for an immunisation campaign this year against the cancer-causing virus.
-
Sharad Pawar Demands Bharat Ratna For Serum Institute Founder Cyrus Poonawalla
Praising the work done by the founder of the Serum Institute of India (SII), in the field of vaccine production, founder of Nationalist Congress Party (NCP) Sharad Pawar demanded that Cyrus Poonawalla be honoured with the Bharat Ratna award.
-
Vaccine Maker Adar Poonawalla To Buy Mansion In London's Mayfair. It Costs...
Billionaire CEO of Serum Institute of India, Adar Poonawalla, has sealed a deal to buy a multi-million-pound mansion in London's Mayfair, the Financial Times reported.
